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Applications of Electroporation in Veterinary Medicine
Introduction & Fundamentals of Electroporation
Figure 2: ECT treatment evolution in a 9-year-old 
gelding. Horse at presentation with 2 sarcoids on the 
left upper eyelid (left image), 2 weeks after 2nd ECT 
session (middle), and 18 weeks post 4th ECT (right). 
(Tamzali et al. 2012).
Devices and Electrodes
Conclusions
Gene Therapy (GET) and DNA immunization
	 -	Cancer	treatment,	vaccinations,	and	metabolic	or	organ-specific	diseases.	
	 -	Efficient	in	various	tissues.	Can	improve	muscle	delivery	up	to	10,000-fold	over	naked	DNA	in	both	small	and	large	animal	species.	
	 -	Has	been	efficient	as	either	a	primary	or	booster	vaccination	strategy	(Venezuelan	Equine	Encephalitis,	Anthrax,	and	Influenza).	
Electroporation	can	be	expected	to	grow	in	the	clinical	practice	use,	as	encouraging	results	have	been	reported	in	animal	models	and	in	several	clinical	trials	using	ECT,	GET,	and	NTIRE.	
However,	the	inability	to	ablate	some	tumors	and	induce	long-term	immune	protection	with	DNA	vaccines	must	be	clarified	and	overcome.
Electrochemotherapy (ECT): administration of an anticancer drug and local delivery of electrical pulses at the tumor site. 
 - Safe for different histological types and as an adjuvant treatment to surgery in companion animals and horses (Fig. 2). 
	 -	Approximately	80%	long	lasting	objective	response	with	minimal	toxicity.	
Nonthermal Irreversible Electroporation (NTIRE):	it	is	an	ablation	method,	leading	to	cell	death	either	directly	through	excessive	
damage or via apoptosis. It spares the tissue scaffold, like large blood vessels and is usually employed in tumors. 
	 -	The	efficacy	of	the	procedure	varies	among	studies	and	treated	organs.
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Applications of Electroporation
Electroporation (EP) is a phenomenon resulting from applying a strong, albeit short, electrical pulse to any cell or tissue, which causes the formation of temporary “pores” in the plasma 
membrane.	These	openings	allow	molecules	that	normally	cross	the	membrane	only	in	minute	amounts	to	readily	pass	through	the	barrier	in	quantity	(Fig.	1).	This	bibliographic	review	
takes a glance at how it works, giving a practical point of view on its most remarkable applications in veterinary medicine. It also introduces the available devices for animal practice.
Figure 1: Simplyfied effects of EP in cells depending on electrical pulse range during therapy
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